Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCXW
Carmell Therapeutics CorporationUS flagNASDAQ Capital Market
0.03
USD
-0.02
- -
558,174.00Market Cap

Income Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Sales/Revenue/Turnover
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
2
6
5
5
+ Selling, General & Admin
1
3
3
4
+ Research & Development
1
2
2
1
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
-2
-6
-5
-5
- Non-Operating (Income) Loss
5
4
11
6
+ Interest Expense, Net
2
4
1
- -
+ Interest Expense
2
4
1
- -
- Interest Income
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
2
- -
10
6
Pretax Income
-6
-9
-16
-11
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-6
-9
-16
-11
- Net Extraordinary Losses (Gains)
- -
- -
-1
- -
+ Discontinued Operations
- -
- -
1
- -
+ Extraord. & Accounting Changes
- -
- -
-2
-1
Income (Loss) Incl. MI
-6
-9
-15
-10
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-6
-9
-15
-10
- Preferred Dividends
- -
1
1
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-7
-10
-16
-10
EBIT
-2
-6
-5
-5
EBITDA
-2
-5
-5
-5
EBITDA Margin (%)
- -
- -
- -
-9,541.79
EBITA
-2
-6
-5
-5
Gross Margin (%)
- -
- -
- -
87.37
Operating Margin (%)
- -
- -
- -
-9,933.82
Profit Margin (%)
- -
- -
- -
-20,605.47
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
Basic EPS from Cont Ops
- -
- -
- -
- -
Diluted Weighted Avg Shares
- -
- -
- -
- -
Diluted EPS, GAAP
- -
- -
- -
- -
Diluted EPS from Cont Ops
- -
- -
- -
- -

Balance Sheet (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Total Current Assets
- -
1
63
1
+ Cash, Cash Equivalents & STI
- -
- -
3
- -
+ Cash & Cash Equivalents
- -
- -
3
- -
+ ST Investments
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
- -
- -
60
- -
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
1
1
1
1
+ Property, Plant & Equip, Net
1
1
1
- -
+ Property, Plant & Equip
2
2
2
1
- Accumulated Depreciation
- -
1
1
1
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
Total Assets
2
2
64
1
+ Payables & Accruals
3
3
6
6
+ Accounts Payable
1
2
4
4
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
2
1
1
1
+ ST Debt
9
3
1
- -
+ ST Borrowings
9
3
1
- -
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
4
2
31
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
4
2
31
- -
Total Current Liabilities
16
7
39
6
+ LT Debt
1
1
1
- -
+ LT Borrowings
- -
- -
- -
- -
+ LT Finance Leases
1
1
1
- -
+ Other LT Liabilities
14
31
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
14
31
- -
- -
Total Noncurrent Liabilities
15
32
1
- -
Total Liabilities
31
40
39
6
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
3
5
83
64
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
3
5
83
64
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-33
-42
-59
-69
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
-30
-38
25
-5
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-30
-38
25
-5
Total Liabilities & Equity
2
2
64
1
Shares Outstanding
19
19
23
29
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
1
1
1
- -
Net Debt
9
3
-2
- -
Net Debt to Equity
-29.05
-7.01
-6.56
-1.78
Tangible Common Equity Ratio
-1,943.08
-2,198.99
38.68
-325.39
Current Ratio
0.01
0.08
1.63
0.16
Cash Conversion Cycle
- -
- -
- -
-10,307.11

Cash Flow Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
+ Net Income
-6
-9
-15
-12
+ Depreciation & Amortization
- -
- -
- -
- -
+ Non-Cash Items
4
3
10
7
+ Stock-Based Compensation
- -
1
1
1
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
4
2
10
6
+ Chg in Non-Cash Work Cap
1
2
-3
1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
- -
+ Inc (Dec) in Accts Payable
1
3
-1
-2
+ Inc (Dec) in Other
- -
- -
-2
2
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-1
-3
-8
-4
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
3
+ Increase in Capital Stock
- -
- -
- -
3
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
-1
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
-1
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
-1
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
2
5
-1
- -
+ Cash From Debt
2
5
2
- -
+ Repayments of Debt
- -
- -
-3
-1
+ Other Financing Activities
-1
-2
13
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
1
4
11
2
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
- -
- -
3
-3
EBITDA
-2
-5
-5
-5
EBITDA Margin (%)
- -
- -
- -
-9,541.79
Free Cash Flow
-1
-3
-8
-4
Net Cash Paid for Acquisitions
- -
- -
- -
1
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
1
-10
-5
Free Cash Flow per Basic Share
- -
- -
- -
- -
Price/Free Cash Flow
- -
- -
- -
- -
Cash Flow to Net Income
0.18
0.38
0.54
0.42
Capital Expenditures
- -
- -
- -
- -